Mechanisms of antibody formation. II. Use of DNP-Ficoll in studies of hapten-specific B-cell responses.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D001402:B-Lymphocytes / Q000276:immunology*; D004140:Dinitrophenols / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D005362:Ficoll / Q000276:immunology*; D006241:Haptens; D006462:Hemolytic Plaque Technique; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D011134:Polysaccharides / Q000276:immunology*; D014747:Vinblastine / Q000494:pharmacology
D004140:Dinitrophenols; D006241:Haptens; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011134:Polysaccharides; D005362:Ficoll; D014747:Vinblastine